US Patent Issued to Satellos Bioscience on Sept. 29 for "AP2 associated kinase 1 inhibitors and uses thereof" (Canadian Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,245, issued on Sept. 29, was assigned to Satellos Bioscience Inc. (Toronto).

"AP2 associated kinase 1 inhibitors and uses thereof" was invented by James Brian Jaquith (Cobourg, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds of Formula (I) having the structure:or a pharmaceutically acceptable salt, deuterated form, stereoisomer, or composition thereof, that can be used to treat or manage a disease or a disorder mediated by AAK1 activity, such as a muscular dystrophy, in a subject in need thereof."

The patent was filed on May 9, 2025, under Application No. 19/204,186.

*For further information, including images, ...